Our Partners
Working with Universities, Industry and Investors to develop your technology within our 12,000 sq. ft custom built biohazardous laboratories and manufacturing facility.

Multinational & SME
We manage the whole journey hands on from start to finish: from concept to design, from development through validation, clinical trials, regulatory submissions and into product manufacturing.
With complete integration and involvement between R&D, in-house manufacture and commercial launch.

ACADEMIA & START UPS
Pre-Spin Out (typical project duration 4-12 months):
- Early proof of concept, design, technology applications, prototyping, market analysis and business planning, regulatory & IP review, academic & business grant applications, spin-out fundraising
Post-Spin Out (typical project duration 18-30 months):
- Full product development, validation, clinical trials, regulatory submissions, product manufacturing and commercial launch
We partner with researchers as early as possible to scope and shape ideas for commercial success
Our early development projects are grant funded – we are named as a collaborator on grant applications
We ensure technologies are industry ready by focusing on clinical need, regulatory, quality and usability in product design and development
All IP generated is transferred to the academic institute

INVESTORS
We partner closely with investors to de-risk commercial opportunities
- We carry out due diligence on potential investment opportunities
- Troubleshoot issues throughout the product lifecycle
- Take on product development and manufacturing
- Accelerate the route to market by reducing time and cost to launch

OUR VALUED PARTNERS
We provide the entire lifecycle, from concept to commercial launch in <4 years for fully CE / FDA compliant and accredited products.
We have found Medtechtomarket to be a productive and professional development partner for a number of projects with the University of Liverpool. These include grant-funded projects in early technology applications and proof of concept, medical device development and prototyping and full in vitro diagnostic development. Throughout our time working with Medtechtomarket, their clear focus on clinical needs and ensuring technologies and products are industry-ready, has progressed each project successfully in a surprisingly short time frame.
University of Liverpool
Medtechtomarket has been our development and manufacturing partner in the development of our diagnostic test for prostate cancer. During that time, they have demonstrated their expertise and knowledge of IVD product design, development and manufacture and supported our business more widely. Acting as an extension of our R&D team, their flexible, methodical and milestone-centred approach has been transparent, productive, and seamless.
Glycoscore
Our company has worked closely with Medtechtomarket for more than three years in the development of an in vitro diagnostic instrument to assess the functioning of a patient’s hemostatic system. From the beginning of the engagement, we were impressed with Dr. Pearce and his team’s knowledge and experience involving diagnostic instrument design, development, and manufacturing.
Entegrion
Medtechtomarket have supported our company’s corporate partnering activities, providing high confidence in the product and the process used to develop it. Their experience and capabilities in manufacturing and knowledge of the IVD market have informed our decision-making regarding product features, and more recently supported efforts toward the initial launch of the system.
Entegrion
Very responsive and consistently demonstrate creativity and expertise in development, manufacturing and problem solving.
Entegrion
Truly functions as a business partner.
Entegrion
The love, pride and passion for their work comes across to me. Not only is this very reassuring, it makes it so much easier to work with them.
Biology of Dying
The team responded to and met our requests to complete the project as per our aggressive timescales. They provided a dedicated point of contact (Project Manager) overseeing the project providing timely updates and information when requested, and they have successfully transferred the product into their product facility, as demonstrated via the manufacture of 3 validation batches which meet the required specifications. This has enabled us to progress one of the company’s key strategic goals which is the clinical and analytical testing of the product in support of a new CE mark application.
AmLo
We continue to work closely with the team at Medtechtomarket and enjoy an excellent all-round relationship. The past year has provided a number of significant project challenges and together we have managed to overcome all of them.
Glycoscore DX
The team show a high level of commitment to ensuring we complete projects to the required standards and specifications. They go above and beyond to ensure that work gets completed on time and providing data we need, for example for grant reporting or applications.
University of Birmingham
I am happy with the ways in which Medtech are currently supporting our project. The project is technically challenging and they have showed commitment to ensuring the test we are developing meets our end user needs, including trying a range of approaches to ensure technical hurdles can be overcome.
University of Birmingham
We are very happy with the level of customer service and technical support from Medtechtomarket and are looking forward to working together on future projects. Anyone I contact within the team are responsive and helpful.
AmLo
Has been a valued partner producing high quality products, supporting our international business, clinical studies and technical matters.
Entegrion
Exceeded expectations, not only delivering on project as originally scoped but also by pitching in on re-formulation of original design.
Presymptom Health
Without the team at Medtechtomarket we would not have the capability or the capacity to undertake this program. A true value-add.
Glycoscore DX
CASE STUDIES
Working in close partnership with our clients, we develop robust, compliant and commercially viable products ready for launch in the chosen market.
Point of Care Haemostasis
Working with a client based in the USA, we developed, manufactured and launched the world’s first…
Home-use Urology Monitor and Device
Medtechtomarket developed a urine collection and monitoring system for adults using indwelling catheters. Our system offered…
Rapid ECG
Medtechtomarket developed a wireless ECG device for use by professionals in primary, acute and hyper-acute care…
Rapid Near-Patient Sepsis Diagnosis
There are approximately 123,000 cases and around 46,000 associated deaths from sepsis reported in England each…
REGISTER FOR INSIGHTS
The MedtechtoMarket team has worked together directly for over 25 years developing, producing and launching products in over 50 countries worldwide.